|
⚲
|
| Keyboard |
| Peter Wirth | |
|---|---|
| Firm | |
| Address | 35 Cambridgepark Drive Cambridge, MA 02140 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Syros Pharmaceuticals Inc | 021-459511 | Director | 129.8 M of 129.8 M |
||
| Centrexion Therapeutics Corp | 021-448502 | Director | 29.1 M of 29.1 M |
||
| Syros Pharmaceuticals Inc | 021-383597 | Director | 90.5 M of 121.6 M |
||
| Syros Pharmaceuticals Inc | 021-303459 | Director | 11.4 M of 11.4 M |
||
| AURA Biosciences Inc | 021-271656 | Director | 11.5 M of 11.5 M |
||
| AURA Biosciences Inc | 021-235305 | Director | 21.0 M of 34.5 M |
||
| AURA Biosciences Inc | 021-222909 | Director | 4.0 M of 4.0 M |
||
| Lysosomal Therapeutics Inc | 021-217238 | Director | 4.8 M of 4.8 M |
||
| AURA Biosciences Inc | 021-209519 | Director | 1.3 M of 1.3 M |
||